ChiCTR2000033012
尚未开始
/
/
/
2020-05-18
/
/
Mayer-Rokitansky-Küster-Hauser (MRKH)
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
In this study, we aim to evaluate the management of women who suffered from MRKH syndrome and evaluate the outcomes of vaginal dilation therapy or surgical therapy and the associated complications. Besides, it is also valuable to study the sexual function of women to guide the future treatment plan for other MRKH women.
单臂
其它
N/A
/
Departmental funding
/
300
/
2020-05-20
2030-04-30
/
1) All women who suffered from MRKH and requested for vaginoplasty; 2) Age >=18 years old.；
登录查看Women who refuse to join the study.；
登录查看Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong
/
再鼎医药2025-10-16
医麦创新药2025-10-16
礼来Lilly2025-10-16
普莱ProteLight2025-10-16
医学新视点2025-10-16
求实药社2025-10-16
药时空2025-10-16
安捷伦临床诊断2025-10-16
药筛2025-10-16
Being科学2025-10-16
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网
